Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein.
Saved in:
| Title: | Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein. |
|---|---|
| Authors: | Munoz Pinto MF; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal., Campbell SJ; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Simoglou Karali C; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Johanssen VA; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Bristow C; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Cheng VWT; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; Leeds Institute of Medical Research, University of Leeds, Leeds, UK., Zarghami N; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Larkin JR; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK., Pannell M; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.; OxSonics Ltd., The Magdalen Centre, Oxford Science Park, Oxford, UK., Hearn A; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Chui C; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Brinquis Nunez B; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Bokma E; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Holgate R; Abzena Ltd., Babraham Research Campus, Babraham, Cambridge, UK., Anthony DC; Department of Pharmacology, University of Oxford, Oxford, UK., Sibson NR; Medical Research Council Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK. |
| Source: | Neuro-oncology [Neuro Oncol] 2022 Jan 05; Vol. 24 (1), pp. 52-63. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noab177 |
